$Kobayashi Pharmaceutical (4967.JP)$
Wait until the stop limit is lifted. The root cause of this situation lies in the internal control system issues and is not due to external factors, so I cannot buy it straightforwardly until there is a specific announcement on how to change the control system in the future.
Wait until the stop limit is lifted. The root cause of this situation lies in the internal control system issues and is not due to external factors, so I cannot buy it straightforwardly until there is a specific announcement on how to change the control system in the future.
Translated
11
If the USA enters stagflation, it seems that essential goods and energy stocks will rise. Petro stocks 2 brands bed.
Translated
2
Will the Bank of Japan rate hike help alleviate the cost burden of importing raw materials from overseas for retail businesses? It is a blow to companies that do not have factories overseas.
Translated
2
I was considering buying more Toyota shares, but it seems to be at a high level and in a downtrend, so I'm putting it on hold. Nissan is at a low level, but I can't buy it because they are focusing on the EV business.
Translated
8
3
Maybe they collected data in the Asian region, but the real estate sector is in bad shape, but e-commerce in China 🇨🇳 is too strong. 😅
Translated
1
The US export restrictions on semiconductors to China are ultimately expected to allow other countries to export to China, which is seen as a market demand hotspot. Cooperation with companies in Taiwan and South Korea in technology is likely to result in an increase in domestic self-sufficiency.
Translated
1
Even with this drop, it's still overvalued. It has excellent growth potential. We have high hopes for increased facility investment and a slight increase in inbound due to the depreciation of the yen.
Translated
+3
2
3